According to DelveInsight's' estimates, the adrenocortical carcinoma market in 7MM is expected to show positive growth, during the forecast period (2024-2034), mainly attributed to the anticipated
Author Bio
A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and investment planning. You ll often find him writing about Obamacare, marijuana, drug and device development, Social Security, taxes, retirement issues and general macroeconomic topics of interest. Follow @TMFUltraLong
For more than a decade, growth stocks have been virtually unstoppable. Historically low lending rates have allowed companies to aggressively borrow in order to hire, innovate, and acquire other businesses. But it might be time for value stocks to shine.
Back in 2016,
Bank of America/Merrill Lynch released a report that examined the performance of growth stocks and value stocks over 90 years (1926-2015). The data showed that value stocks outperformed over the very long run (17% vs. 12.6%). What s more, value stocks have tended to perform much better than growth stocks during the early stages of a bull market, w